IMAC Holdings

BACK · OTC

$0.0001+$0.0004 (−133.33%)TodayMarket closed · Oct 20, 12:17 PM ET

No price history for this range.

About BACK

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Franklin, Tennessee and currently employs 15 full-time employees. The company went IPO on 2019-02-13. The Company, through its subsidiary, Ignite Proteomics LLC (Ignite Proteomics), leverages its multi-analyte proteomic assay to help oncologists pinpoint the effective targeted therapies for each patient. Its product is a patented Reverse Phase Protein Array (RPPA) technology platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Ignite Proteomics operates a CLIA-certified and CAP-accredited laboratory and offers single-gene tests by evaluating entire protein pathways in cancer cells. Its commercially available lab developed test (LDT), the Ignite RPPA Assay for Breast Cancer, is being utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.

Employees: 15
Headquarters: Franklin, Tennessee
Listed: Feb 13, 2019
Sector: Health Care
Industry: Biotechnology
Website: imacregeneration.com

Leadership

IMAC Holdings executives
Name	Title	Since	Age
Faith Zaslavsky	—	—	50
Sheri Gardzina	—	—	56
Jason Lobel	—	—	—
Saundra Pelletier	—	—	—
Peter Beitsch	—	—	64
Jeffrey Busch	—	—	67
Maurice Evans	—	—	45
Matthew Schwartz	—	—	51
Kim Golodetz	—	2022	—

Revenue by product and region

Fiscal year ended Dec 31, 2021: $14.39M total revenue

By product

Health Care, Patient Service [Member]$14.16M98.5%
Management Service [Member]$216.07K1.5%
Others income [Member]$6.09K0.0%

Similar companies

Companies in the same industry as IMAC Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.